Pharmaceuticals

SANAI HEALTH GP

SANAI HEALTH GP released FY2025 Q3 earnings on March 31 (BJT), actual revenue HKD 21.14 M, actual EPS HKD -0.0399

SANAI HEALTH GP released FY2025 9 Months Earnings on March 31, 2026 (BJT), actual revenue HKD 72.27 M, actual EPS HKD -0.1168

SANAI HEALTH GP released FY2025 Q4 earnings on March 31 During-Market (BJT), actual revenue HKD 21.51 M, actual EPS HKD -0.0406

SANAI HEALTH GP released FY2025 Annual Earnings on March 31 During-Market (BJT), Actual Revenue: HKD 93.89 M, Actual EPS: HKD -0.1575

SANAI HEALTH GP to Release FY2025 Earnings on March 31, 2026, During-Market BJT

SANAI HEALTH GP released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 25.29 M and EPS of HKD -0.038

SANAI HEALTH GP released FY2025 Semi-Annual earnings on August 28 During-Market (BJT), actual revenue HKD 51.13 M, actual EPS HKD -0.0769

SANAI HEALTH GP released FY2025 Q2 earnings on August 28 During-Market BJT, actual revenue HKD 25.84 M, actual EPS HKD -0.0388

SANAI HEALTH GP to Release FY2025 Semi-Annual Earnings on August 28, 2025, Pre-Market BJT

Sanai Health Group Releases 2024 Annual Performance, Revenue Decreases by 20.92%

SANAI HEALTH GP released FY2024 Q3 earnings on March 31 (BJT) with actual revenue of 0 HKD and EPS of 0 HKD

SANAI HEALTH GP released FY2024 9 Months Earnings on March 31 (BJT), with actual revenue of 39.64 M HKD and EPS of 0.0781 HKD

SANAI HEALTH GP released FY2024 annual earnings on March 31 After-Market (BJT), actual revenue 92.25 M HKD, actual EPS 0.0364 HKD

SANAI HEALTH GP released FY2024 Q4 earnings on March 31 After-Market BJT, with actual revenue of 0 HKD and actual EPS of 0 HKD

SANAI HEALTH GP to Release FY2024 Earnings on March 31 After-Market BJT

Announcement of Board Changes at San Ai Health Group

San Ai Health Group Releases H1 2024 Financial Results

SANAI HEALTH GP released FY2024 Q2 earnings on August 30 After-Market BJT, actual revenue HKD 19.73 M, actual EPS HKD 0.0388

Sannai Health Group Expects Significant Decrease in Revenue and Profit

Sanai Health Group Share Consolidation

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

01889

516930

589720

512010

512290

588130

159929

510660

159849

159837

Sanai Health Industry Group has been ordered by the High People’s Court of Beijing to pay approximately RMB120 million in a finance lease dispute involving its subsidiary, Fujian Sanai. The judgment includes principal, interest, and legal fees, with the company and two individuals held jointly liable. While this litigation will impact the company's cash reserves and net assets, Sanai Health has sufficient funds to cover the judgment. The management is evaluating the effects on its 2026 financial statements and plans to seek compensation from other parties involved.

Tip Ranks

Minsheng Royal CSI Biotechnology Theme ETF

Guotai SSE STAR Brand Name Drug ETF

E Fund CSI 300 Health Care ETF

Guotai CSI Bio-medicine ETF

ChinaAMC SSE STAR Biology and Medicine ETF

China Universal 800 Health Care ETF

ChinaAMC SSE Health Care ETF Initiating Fund

China Merchants CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

Sanai Health Hit With Final RMB120 Million Judgment in Beijing Lease Dispute

SANAI HEALTH GP expects to record a loss of between RMB 25.5 million and RMB 27.5 million for the year ending December 31, 2025, compared to a profit of approximately RMB 3.4 million for the same period in 2024

AASTOCKS

"Profit Warning" SANAI HEALTH GP expects to incur a loss of up to 27.5 million RMB last year

SANAI HEALTH GP fell 15.52%; CSPC Pharmaceutical Group rose 0.80%, with a transaction volume of HKD 727 million; China Biologic Products Holdings rose 1.33%, with a transaction volume of HKD 506 million; Hansoh Pharmaceutical rose 0.05%, with a transaction volume of HKD 330 million; Heng Rui Medicine rose 2.48%, with a market value of HKD 493.1 billion

HK Stock Alerts

Hong Kong Stock Movement: SANAI HEALTH GP plummets 15.52%, active capital flow attracts market attention

SANAI HEALTH GP rose 18.00%; CSPC Pharmaceutical Group rose 0.41%, with a transaction volume of HKD 828 million; China Biologic Products Holdings fell 0.29%, with a transaction volume of HKD 459 million; Hansoh Pharmaceutical rose 1.07%, with a transaction volume of HKD 229 million; Heng Rui Medicine rose 0.56%, with a market value of HKD 477.2 billion

Hong Kong Stock Movement: SANAI HEALTH GP rises 18%, no news support, capital flow attracts market attention?

According to the Zhitong Finance APP, SANAI HEALTH GP released its interim results for the six months ending June 30, 2025, reporting revenue of 47.222 million yuan, an increase of 28.57% year-on-year; the loss attributable to shareholders was 10.861 million yuan, compared to a profit of 9.971 million yuan in the same period last year; the loss per share was 0.071 yuan. The announcement stated that the increase in revenue was mainly due to the increase in revenue from the sale of pharmaceutical products by Beijing Hangyang during this period

Zhitong

SANAI HEALTH GP released its interim results, with a loss attributable to shareholders of 10.861 million yuan, turning from profit to loss year-on-year

SANAI HEALTH GP issued a profit warning, expecting to incur a shareholder loss of approximately HKD 11.5 million to HKD 14 million for the six months ending June 30, 2025, a significant decrease from the attributable profit of HKD 9.8 million in the same period of 2024. The loss is mainly due to the inability to repeat the non-recurring income of approximately HKD 17.04 million obtained in the same period of 2024, as well as an increase in distribution costs and administrative expenses of approximately HKD 4.6 million during the current period

SANAI HEALTH GP issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately 11.5 million to 14 million yuan

According to the Zhitong Finance APP, SANAI HEALTH GP announced that Professor Zhang Rongqing has resigned as executive director to devote more time to his personal affairs, effective from June 26, 2025 (resignation)

SANAI HEALTH GP: Zhang Rongqing resigns as executive director

According to the Zhitong Finance APP, SANAI HEALTH GP announced that Mr. Chen Chengqing will no longer serve as an executive director from the conclusion of the shareholders' annual meeting. The board has proposed (i) to remove Zhang Rongqing from the position of executive director; and (ii) to convene a special shareholders' meeting in accordance with the bylaws to consider and, if deemed appropriate, approve the proposed removal

SANAI HEALTH GP: Chen Chengqing is no longer an executive director

SANAI HEALTH GP announced that the company has filed a second appeal to the Beijing High People's Court regarding the civil judgment on May 23, requesting the court to rule that the financing lease agreement and guarantees are invalid and to dismiss all claims made by the plaintiff

SANAI HEALTH GP has filed a second appeal regarding the civil judgment

SANAI HEALTH GP released its annual results for the year ending December 31, 2024, with revenue of 85.217 million yuan, a year-on-year decrease of 20.92%; profit attributable to shareholders of 4.892 million yuan, a year-on-year decrease of 73.75%; and earnings per share of 3.37 cents. The announcement pointed out that the decrease in revenue was mainly due to a decline in sales of self-produced pharmaceutical products and other non-competitive pharmaceutical products, as well as a significant drop in interest income from financing leasing business

SANAI HEALTH GP released its annual performance, with shareholders' profit attributable to shareholders of HKD 4.892 million, a year-on-year decrease of 73.75%

SANAI HEALTH GP(01889.HK)